NDC 62756-591
liothyronine sodium 50 ug tablet
On the label: Caraco Pharmaceutical Laboratories, Ltd..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Dadra, India | Makes it and tests it | Problems found, fixed voluntarilyMar 29, 2019 · 5 inspections |
Recalls
- Dec 4, 2023 · Class II · Sun Pharmaceutical Industries Inc
Failed Impurities/Degradation Specifications
Lots: Lot DND0059A Expires 12/2023 Lot DND0060A Expires 12/2023 Lot DND0061A Expires 12/2023 Lot DND0062A Expires 01/2024 Lot DND0063A Expires 01/2024 Lot DND0064A Expires 01/2024 Lot DND0065A Expires 01/2024 Lot DND0180A Expires 01/2024 Lot DND0181A Expires 01/2024 Lot DND0182A Expires 01/2024 Lot DND01… - Oct 20, 2023 · Class II · Sun Pharmaceutical Industries Inc
Failed Impurities/Degradation Specifications.
Lots: Lot #: DND0058A, Exp. Date 12/2023 - Oct 20, 2023 · Class II · Sun Pharmaceutical Industries Inc
Failed Impurities/Degradation Specifications.
Lots: Lot #: DNC2204A, Exp. Date 11/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Liothyronine: every company that makes it
- Form
- tablet, oral
- Strength
- 50 ug
- Approval
- ANDA ANDA091382
- On the market since
- Nov 28, 2019
- Package NDCs
62756-591-0162756-591-0862756-591-1862756-591-8362756-591-88- Official label
- DailyMed (National Library of Medicine), updated Oct 3, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?